On the recordMarch 11, 2019
So how is HHS going to hold pharmaceutical manufacturers accountable for drug-marketing strategies that are boosting profits while harming our communities?
Source
congress.govEditor's note · Context
Sarbanes questions HHS accountability regarding harmful pharmaceutical marketing practices.
Share
More from John Sarbanes
Apr 10, 2024
I thank Congressman Mfume for organizing this very important and special tribute. It is a tribute, as you have already heard, to the six hardworking men who lost their lives during this collapse of the bridge on March 26. They got up that…
Apr 18, 2023
I do also want to commend my colleague, Representative Blunt Rochester, for the work that she has been doing.
Apr 25, 2023
I have to say when we passed that Inflation Reduction Act, it was the first time in a long time that I did not feel powerless or feel that we were powerless in the face of climate change coming at us.
Other voices in this conversation
